FOSUN PHARMA: JOINT ANNOUNCEMENT - PROGRESS UPDATE IN RELATION TO THE PRE-CONDITIONAL PRIVATISATION OF HENLIUS BY FOSUN NEW MEDICINE BY WAY OF MERGER BY ABSORPTION OF HENLIUS
FOSUN PHARMA: JOINT ANNOUNCEMENT - PROGRESS UPDATE IN RELATION TO THE PRE-CONDITIONAL PRIVATISATION OF HENLIUS BY FOSUN NEW MEDICINE BY WAY OF MERGER BY ABSORPTION OF HENLIUS
FOSUN PHARMA: JOINT ANNOUNCEMENT - PROGRESS UPDATE IN RELATION TO THE PRE-CONDITIONAL PRIVATISATION OF HENLIUS BY FOSUN NEW MEDICINE BY WAY OF MERGER BY ABSORPTION OF HENLIUS
FOSUN PHARMA: JOINT ANNOUNCEMENT - (1) REVISED PROPOSED PRE-CONDITIONAL PRIVATISATION OF HENLIUS BY FOSUN NEW MEDICINE BY WAY OF MERGER BY ABSORPTION OF HENLIUS (2) PROPOSED WITHDRAWAL OF LISTING AND (3) POSSIBLE DISCLOSEABLE TRANSACTION OF FOSUN PHARMA
FOSUN PHARMA: JOINT ANNOUNCEMENT - PROGRESS UPDATE ON THE PRE-CONDITIONAL PRIVATISATION OF HENLIUS BY FOSUN NEW MEDICINE BY WAY OF MERGER BY ABSORPTION OF HENLIUS
FOSUN PHARMA: JOINT ANNOUNCEMENT - DELAY IN DESPATCH OF COMPOSITE DOCUMENT RELATING TO PROPOSED PRE-CONDITIONAL PRIVATISATION OF HENLIUS BY FOSUN NEW MEDICINE BY WAY OF MERGER BY ABSORPTION OF HENLIUS
FOSUN PHARMA: JOINT ANNOUNCEMENT (1) PROPOSED PRE-CONDITIONAL PRIVATISATION OF HENLIUS BY FOSUN NEW MEDICINE BY WAY OF MERGER BY ABSORPTION OF HENLIUS AND (2) PROPOSED WITHDRAWAL OF LISTING FULFILMENT OF PRE-CONDITION TO THE POTENTIAL SHARE ALTERNATIVE OFFER
FOSUN PHARMA: JOINT ANNOUNCEMENT (1) PROPOSED PRE-CONDITIONAL PRIVATISATION OF HENLIUS BY FOSUN NEW MEDICINE BY WAY OF MERGER BY ABSORPTION OF HENLIUS (2) PROPOSED WITHDRAWAL OF LISTING (3) POSSIBLE DISCLOSEABLE TRANSACTION OF FOSUN PHARMA AND (4) RESUMPTION OF TRADING
FOSUN PHARMA: ANNUAL GENERAL MEETING; MANDATE TO ISSUE INTERBANK MARKET DEBT FINANCING INSTRUMENTS; PROVISION OF LOAN TO FOSUN KITE (A JOINT VENTURE) IN PROPORTION TO EQUITY INTEREST; RENEWED AND ADDITIONAL GUARANTEE QUOTA; GRANT OF GENERAL MANDATE TO ISSUE A SHARES AND
FOSUN PHARMA: EXCHANGE NOTICE - RESUMPTION OF TRADING
FOSUN PHARMA: RESUMPTION OF TRADING
FOSUN PHARMA: TRADING HALT
FOSUN PHARMA: EXCHANGE NOTICE - TRADING HALT
FOSUN PHARMA: VOLUNTARY ANNOUNCEMENT - APPROVAL FOR REGISTRATION OF THE PUBLIC ISSUANCE OF CORPORATE BONDS
FOSUN PHARMA: RESULTS OF THE RESERVED GRANT UNDER THE 2022 RESTRICTED A SHARE INCENTIVE SCHEME AND CHANGES TO THE REGISTERED CAPITAL AND ARTICLES OF ASSOCIATION
FOSUN PHARMA: VOLUNTARY ANNOUNCEMENT - INCREASE IN SHAREHOLDING BY A CONTROLLING SHAREHOLDER
FOSUN PHARMA: (1) ANNOUNCEMENT IN RELATION TO THE RESERVED GRANT OF RESTRICTED SHARES UNDER THE 2022 RESTRICTED A SHARE INCENTIVE SCHEME AND (2) VOLUNTARY ANNOUNCEMENT IN RELATION TO THE GRANT OF RESERVED UNITS UNDER THE 2022 H SHARE EMPLOYEE SHARE OWNERSH
FOSUN PHARMA: ANNUAL GENERAL MEETING; PROVISION OF LOAN TO FOSUN KITE (A JOINT VENTURE) IN PROPORTION TO EQUITY INTEREST; ADJUSTMENT OF INEDS ALLOWANCE; AMENDMENTS TO THE RELATED PARTY TRANSACTION MANAGEMENT SYSTEM; ELECTION OF SUPERVISOR; RENEWED AND ADDI
FOSUN PHARMA: APPROVAL FROM CHINA SECURITIES REGULATORY COMMISSION IN RELATION TO POSSIBLE ISSUANCE OF H SHARE OR/AND H SHARE CONVERTIBLE BONDS
FOSUN PHARMA: RESULTS OF FIRST GRANT OF RESTRICTED SHARES TO PARTICIPANTS UNDER THE 2022 RESTRICTED A SHARE INCENTIVE SCHEME AND CHANGES TO THE REGISTERED CAPITAL AND ARTICLES OF ASSOCIATION